Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence

    Access Status
    Fulltext not available
    Authors
    Higgs, Peter
    Sacks-Davis, R.
    Gold, J.
    Hellard, M.
    Date
    2011
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Higgs, P. and Sacks-Davis, R. and Gold, J. and Hellard, M. 2011. Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence. Hepatitis Monthly. 11 (7): pp. 513-518.
    Source Title
    Hepatitis Monthly
    ISSN
    1735-143X
    School
    National Drug Research Institute (NDRI)
    URI
    http://hdl.handle.net/20.500.11937/54407
    Collection
    • Curtin Research Publications
    Abstract

    Background: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. Objectives: We reviewed the literature to obtain an evidence base for these common exclusion criteria. Materials and Methods: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. Results: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. Conclusions: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treatment routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. © 2011 Kowsar M.P.Co. All rights reserved.

    Related items

    Showing items related by title, author, creator and subject.

    • The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
      Roxburgh, A.; Livingston, Michael ; Dietze, Paul; Nielsen, S.; Cogger, S.; Bartlett, M.; Day, C.; Latimer, J.; Jauncey, M.; Clark, N. (2023)
      Objectives: The COVID-19 pandemic disrupted service provision of harm reduction and drug treatment services for people who inject drugs in many countries. The two supervised injecting facilities (SIFs) in Sydney and ...
    • AIDS and injecting drug use: very risky behaviour in a Perth sample of injecting drug users
      Loxley, Wendy; Hawks, D. (1994)
      This research was carried out in 1990 to examine high-risk injecting and sexual behaviour in a sample of injecting drug users (IDUs) in Perth. The study was a cross-sectional survey with a convenience sample drawn from ...
    • Injecting-related injury and disease among clients of a supervised injecting facility
      Salmon, A.; Dwyer, Robyn; Jauncey, M.; van Beek, I.; Topp, L.; Maher, L. (2009)
      Background: The process of drug injection may give rise to vascular and soft tissue injuries and infections. The social and physical environments in which drugs are injected play a significant role in these and other ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.